Jacobs Levy Equity Management Portfolio holdings

Jacobs Levy Equity Management's Q2 2015 Portfolio in Review

As of Q2 2015, Jacobs Levy Equity Management held 928 positions worth $5.26B, down 11% from $5.88B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Jacobs Levy Equity Management withdrew a net $615M in Q2 2015, closing 132 positions and reducing 368 holdings. Its most notable exit was BROADCOM CORP CL-A, an estimated $31.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Jacobs Levy Equity Management opened a new position in UnitedHealth worth $43.4M.

• Jacobs Levy Equity Management's largest Q2 2015 buy was UnitedHealth: 355,991 shares worth $43.4M.
• Jacobs Levy Equity Management added most to Bristol-Myers Squibb in Q2 2015, an estimated $43.8M increase.
• Jacobs Levy Equity Management's biggest Q2 2015 reduction was Microsoft, cutting an estimated $70.8M.
• Jacobs Levy Equity Management fully exited BROADCOM CORP CL-A in Q2 2015, selling an estimated $31.3M.
• Jacobs Levy Equity Management's ten largest holdings make up 14% of its $5.26B portfolio in Q2 2015.
• Jacobs Levy Equity Management opened 151 new positions and closed 132 in Q2 2015.
• Jacobs Levy Equity Management's portfolio value fell 11% quarter-over-quarter to $5.26B.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2015, filed 14 Aug 2015.